BCR	B-cell receptor
BTK	Bruton’s tyrosine kinase
CAR	Chimeric antigen receptor
CDK	Cyclin-dependent kinase
CR	Complete remission
HDT-ASCT	High-dose therapy–Autologous stem cell transplantation
MCL	Mantle cell lymphoma
MIPI	MCL international prognostic index
MRD	Minimal residual disease
NK	Natural killer (cells)
ORR	Overall response rate (= complete and partial remissions)
OS	Overall survival
PD	Programmed cell death
PFS	Progression-free survival
PI3K	Phosphoinositide-3 kinase
PD-L1/2	PD ligand 1/2
PR	Partial remission
R-CHOP	Rituximab + cyclophosphamide + doxorubicin + vincristine + prednisone
R-DHAP	Rituximab + dexamethasone + high-dose cytarabine + cisplatin
RM	Rituximab maintenance
R/R-MCL	Relapsed/refractory MCL